Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 20:4:189-206.
doi: 10.1146/annurev-biodatasci-122320-120920. Epub 2021 May 11.

Mutational Signatures: From Methods to Mechanisms

Affiliations

Mutational Signatures: From Methods to Mechanisms

Yoo-Ah Kim et al. Annu Rev Biomed Data Sci. .

Abstract

Mutations are the driving force of evolution, yet they underlie many diseases, in particular, cancer. They are thought to arise from a combination of stochastic errors in DNA processing, naturally occurring DNA damage (e.g., the spontaneous deamination of methylated CpG sites), replication errors, and dysregulation of DNA repair mechanisms. High-throughput sequencing has made it possible to generate large datasets to study mutational processes in health and disease. Since the emergence of the first mutational process studies in 2012, this field is gaining increasing attention and has already accumulated a host of computational approaches and biomedical applications.

Keywords: cancer; cancer evolution; computational models; mutagenic processes; mutational signatures; population genetics.

PubMed Disclaimer

References

    1. Pinto Y, Gabay O, Arbiza L, Sams AJ, Keinan A, Levanon EY. 2016. Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity. Genome Res. 26:579–87 - PMC - PubMed
    1. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979–93 - PMC - PubMed
    1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio S, Behjati S, et al. 2013. Signatures of mutational processes in human cancer. Nature 500:415–21 - PMC - PubMed
    1. Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. 2013. Deciphering Signatures of Mutational Processes Operative in Human Cancer. Cell Rep. 3:246–59 - PMC - PubMed
    1. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, et al. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913–17 - PubMed

Publication types

LinkOut - more resources